Home Cleaved SLPI, a novel biomarker of chymase activity
Article
Licensed
Unlicensed Requires Authentication

Cleaved SLPI, a novel biomarker of chymase activity

  • Stanley M. Belkowski , John Masucci , Andrew Mahan , Jukka Kervinen , Matthew Olson , Lawrence de Garavilla and Michael R. D'Andrea
Published/Copyright: August 19, 2008
Biological Chemistry
From the journal Volume 389 Issue 9

Abstract

Secretory leukocyte protease inhibitor (SLPI) is a protease inhibitor of the whey acidic protein-like family inhibiting chymase, chymotrypsin, elastase, proteinase 3, cathepsin G and tryptase. Performing in vitro enzymatic assays using both Western blotting and liquid chromatography/mass spectrometry techniques we showed that, of the proteases known to interact with SLPI, only chymase could uniquely cleave this protein. The peptides of the cleaved SLPI (cSLPI) remain coupled due to the disulfide bonds in the molecule but under reducing conditions the cleavage can be observed as peptide products. Subsequent ex vivo studies confirmed the presence of SLPI in human saliva and its susceptibility to cleavage by chymase. Furthermore, inhibitors of chymase activity are able to inhibit this cleavage. Human saliva from both normal and allergic individuals was analyzed for levels of cSLPI and a correlation between the level of cSLPI and the extent of allergic symptoms was observed, suggesting the application of cSLPI as a biomarker of chymase activity in humans.


Corresponding author

Received: 2007-11-8
Accepted: 2008-5-13
Published Online: 2008-08-19
Published in Print: 2008-09-01

©2008 by Walter de Gruyter Berlin New York

Downloaded on 10.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/BC.2008.138/html
Scroll to top button